Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Genital Neoplasms, Female × rucaparib × Clear all

Sponsor

Conditions

Fallopian Tube Neoplasms 8 Ovarian Neoplasms 7 Prostatic Neoplasms 6 Endometrial Neoplasms 5 Carcinoma, Ovarian Epithelial 5 Breast Neoplasms 5 Recurrence 3 Pancreatic Neoplasms 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Small Cell Lung Carcinoma 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Urethral Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Sarcoma 1 Prostate Cancer Metastatic 1 Primary Myelofibrosis 1 Pathologic Complete Response 1 Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Metastatic Castration Resistant Prostate Cancer 1 Mental Retardation, X-Linked, With Or Without Seizures, Arx-Related 1 Lymphoma, Non-Hodgkin 1

Interventions

pembrolizumab 2 Pemetrexed 1 Palliative Care 1 Paclitaxel 1 Gemcitabine 1 Educational Status 1 Carboplatin 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡